Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Companies
  4. /
  5. Anna Olak-Popko, MD, Warsaw, Poland – FDA Inspections
Company
•Poland

Anna Olak-Popko, MD, Warsaw, Poland – FDA Inspections

Inspection records and compliance data for Anna Olak-Popko, MD in Warsaw. 1 FDA inspection on record, last inspected September 19, 2017.

Sign in to open in Dashboard
Company Profile

This profile covers Anna Olak-Popko, MD based in Warsaw, Poland.

FDA Inspection History

FDA inspections
1
OAI
0
VAI
0
NAI
1
Form 483s
0
Warning letters
0

Inspected September 19, 2017.

FDA inspections (1)

DateResultFDA center(s)Insp. #
September 19, 2017NAIHuman Drugs · Bioresearch Monitoring1028074
FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Barbara Steinborn, M.D.
Jaroslaw Niebrzydowski
Dr. Iwona Glogowska
KassurSiemienska, Barbara
Pawel Hrycaj, M.D.
Dagmara Makowska Mainka
Agnieszka Zielinska, M.D., Ph.D.
Zbigniew Hebzda, MD, PhD
Rafal Drozda
Hanna Pogorzelska, M.D.
Company Information

Name

Anna Olak-Popko, MD

FEI Number

3013694321

Address

Mtz Clinical Research Sp. Z O.O., Ul. Adolfa Pawinskiego 5, Warsaw, Poland

Country

Poland

ID: 623bba61-8335-44cd-bd99-d4d6c29d54d5

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.